AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Celldex Therapeutics, Inc.

$30.10 +$3.09 (+11.44%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$29.89
Day Range
$29.20$30.21
Year Range
$22.10$45.14
Market Cap
2.36B
AVG Volume
1.3M
Trailing/Forward PE
-6.9/-
PEG ratio
-0.61
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
02.5M5M7.5M10M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLDX Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q2112K
26 Q1820K
25 Q41.5M
25 Q32.6M
25 Q25.79M
25 Q17.56M
24 Q47.02M
24 Q39.98M
24 Q28.3M
24 Q16.07M
Net Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLDX Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-300.59M
26 Q1-283.69M
25 Q4-258.8M
25 Q3-224.53M
25 Q2-199.61M
25 Q1-178.85M
24 Q4-157.86M
24 Q3-154.08M
24 Q2-150.22M
24 Q1-144.88M
Operating Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLDX Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-325.86M
26 Q1-309.1M
25 Q4-287.4M
25 Q3-256.24M
25 Q2-234.75M
25 Q1-217.21M
24 Q4-195.08M
24 Q3-186.68M
24 Q2-175.79M
24 Q1-162.68M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: CLDX

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 9 Nov 2026.

Celldex Therapeutics, Inc.
CLDX
Stockpicker

Video analysis: CLDX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CLDX

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.